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Abstract
 
Tryptophan (TRP) is the precursor of melatonin, the pri-
mary secretory product of the pineal gland. Hepatic heme
deficiency decreases the activity of liver tryptophan pyrro-
lase, leading to increased plasma TRP and serotonin. As a
paradox, patients with attacks of acute intermittent porphy-
ria (AIP), exhibit low nocturnal plasma melatonin levels.
This study using a rat experimental model was designed to
produce a pattern of TRP and melatonin production similar
to that in AIP patients.
Pineal melatonin production was measured in response
to: (
 
a
 
) a heme synthesis inhibitor, succinylacetone, (
 
b
 
) a
heme precursor, 
 
d
 
-aminolevulinic acid (Ala), (
 
c
 
) a structural
analogue of Ala, 
 
g
 
-aminobutyric acid. Studies were per-
formed in intact rats, perifused pineal glands, and pinealo-
cyte cultures. Ala, succinylacetone, and 
 
g
 
-aminobutyric
acid significantly decreased plasma melatonin levels inde-
pendently of blood TRP concentration. In the pineal gland,
the key enzyme activities of melatonin synthesis were un-
changed for hydroxyindole-
 
O-
 
methyltransferase and de-
creased for 
 
N
 
-acetyltransferase.
Our results strongly suggest that Ala overproduced by the
liver acts by mimicking the effects of 
 
g
 
-aminobutyric acid
on pineal melatonin production. These data could account
for the low plasma melatonin in AIP. They also support the
view that Ala acts as a toxic element in the pathophysiology
of AIP. (
 
J. Clin. Invest.
 
 1996. 97:104–110.) Key words: por-
phyria 
 
•
 
 melatonin 
 
•
 
 
 
d
 
-aminolevulinic acid 
 
•
 
 tryptophan 
 
•
 
g
 
-aminobutyric acid
 
Introduction
 
Acute intermittent porphyria (AIP)
 
1
 
 is a dominant inherited
disease due to a defect in the third heme pathway enzyme por-
phobilinogen deaminase (E.C.4318, porphobilinogen [PBG]
deaminase) (1). AIP is characterized by intermittent acute at-
tacks of neurologic dysfunction that may affect the peripheral,
autonomic, or central nervous system. The pathophysiology is
still poorly understood and biochemical findings are related to
a lack of heme mainly in the liver. In plasma, during acute at-
tacks of AIP, heme precursors, 
 
d
 
-aminolevulinic acid (Ala),
and PBG, are increased (2).
Two major hypotheses, a lack of hemoproteins or a toxic
effect of accumulation of heme precursors, have been sug-
gested to explain neurologic disturbances, but few supporting
results have been published.
Two recent studies have provided incremental advances:
Firstly, in a chemically induced porphyric rat model, the
plasma concentration and brain uptake of tryptophan (TRP)
was enhanced and serotonin (5HT) synthesis increased in the
nervous system (3, 4). These increases in TRP and 5HT con-
centrations were partly due to the hepatic heme deficiency de-
creasing the activity of the liver cytosolic enzyme (heme-
dependent) tryptophan pyrrolase (5–7).
Secondly, a study on AIP in 12 women has demonstrated a
rise in whole blood 5HT and total plasma tryptophan during
the attacks whereas day and nighttime melatonin concentra-
tions were dramatically decreased, although melatonin is pro-
duced from TRP (8). In this latter study, and as expected, in-
jection of heme lowered heme precursors (Ala and PBG),
TRP, and 5HT to normal levels (9) but did not increase mela-
tonin concentrations (8).
The biochemical changes that cause the decrease in circu-
lating melatonin remain unknown. Melatonin is synthesized in
the pineal gland by the conversion of tryptophan to serotonin,
which is then acetylated by 
 
N
 
-acetyltransferase (NAT) to form
 
N
 
-acetylserotonin (10). 
 
N
 
-acetylserotonin is subsequently con-
verted to melatonin by the enzyme hydroxyindole-
 
O
 
-methyl-
transferase (HIOMT) (11). The pineal hormone is linked to
the light–dark cycle through low daytime and high nighttime
activity of NAT, the pineal rate-limiting enzyme (10). NE is
the major neurotransmitter of the biochemical pathways con-
trolling NAT activation via 
 
b
 
1 and 
 
a
 
 receptors on the pinealo-
cyte (10). Melatonin is intimately related to the control of cir-
cadian rhythmic functions and their synchronization (12, 13). It
has been implicated in human and mammalian physiology and
pathology as well as in reproduction, chronobiological, and
psychoneuroendocrine functions (13, 14). The physiological
impact of melatonin secretion is in good correlation with clini-
 
Address correspondence to Yves Nordmann, Laboratoire de Bio-
chimie, Hôpital Louis Mourier, 92701 Colombes Cedex, France.
Phone: 33-1-47-60-6335; Fax: 33-1-47-60-6703.
 
Received for publication 22 July 1994 and accepted in revised form
18 September 1995.
 
1. 
 
Abbreviations used in this paper:
 
 5HT, serotonin; AIP, acute inter-
mittent porphyria; Ala, 
 
d
 
-aminolevulinic acid; GABA, 
 
g
 
-aminobutyric
acid; HIOMT, hydroxyindole-
 
O
 
-methyltransferase; NAT, 
 
N
 
-acetyl-
transferase; PBG, porphobilinogen; SA, succinylacetone; TRP, tryp-
tophan.
 
 Melatonin and Acute Intermittent Porphyria
 
105
 
cal features of acute attacks in AIP. Indeed, there is great in-
traindividual variability in the clinical expression of AIP, and
the intermittent and cyclic nature of the attacks is well known.
There is often a prodromal phase several days before the acute
attack, with disturbances such as insomnia, depression, anor-
exia, and mood changes.
In this paper, we present a method suitable for analysis of
the effect of heme deficiency and/or an excess of heme precur-
sor Ala on melatonin production in rats. Ala is a structural an-
alogue of the amino acid neurotransmitter 
 
g
 
-aminobutyric
acid (GABA), therefore, we evaluated the effect of GABA
under our experimental conditions (15).
This study was also designed to reproduce and try to ex-
plain in a rat model the coexistence of a low plasma melatonin
concentration with a high circulating TRP level as previously
observed in acute attacks of AIP (Fig. 1). We have studied the
nocturnal response of rat pineal melatonin production to heme
deficiency induced by a potent inhibitor, succinylacetone (SA),
to Ala accumulation, and to their cumulative effect as it occurs
in acute attacks of AIP. To do this, we measured the circulat-
ing concentrations of TRP and melatonin and the activities of
the pineal enzymes NAT and HIOMT, in vivo, to investigate
indirect effects (i.e., those mediated by the liver). We also per-
formed in vitro investigations on perifused pineal glands and
isolated pineal cell cultures to detect any direct effect of SA,
Ala, and GABA on basal- and adrenergic-stimulated pineal
melatonin production.
 
Methods
 
Chemicals.
 
Ala, GABA, NE, and SA (4, 6-dioxoheptanoic acid)
were purchased from Sigma Chemical Co. (St. Louis, MO). Melato-
nin was purchased from Fluka Chemie AG (Buchs, Switzerland), 
 
125
 
I-
labeled melatonin from Dositek (Orsay, France), rabbit antimelato-
nin antiserum and anti-Ig antiserum were from INRA (Tours,
France).
 
Rat synchronization.
 
80 4–5-wk-old (100–120 g) male albino
Wistar rats (IFFA-CREDO, L’Arbresle, France) were housed four
rats per cage with food and water ad lib. 3 wk before each experi-
ment, the rats were synchronized with a lighting regimen of alternat-
ing 12 h light and 12 h darkness. They were housed in a chronobio-
logic animal facility (Enceinte Autonome d’Animalerie, Ref E 110-
SP-6, ESI Flufrance) with a light intensity of 3.1–3.8 
 
m
 
W/cm
 
2
 
 in the
cages. The chronobiologic facility was equipped with equispaced,
sound-proof, temperature-controlled (21
 
6
 
1.0
 
8
 
C) compartments pro-
vided with filtered air. Each compartment had its own lighting con-
trol. This procedure allowed us to explore several circadian stages at
the same time (e.g., 7 and 19 h after light onset).
 
Experimental protocol.
 
The rats were divided into five groups of
16 animals and synchronized for 3 wk. They were then fasted for 4 d
with water ad lib. The control group was injected intraperitoneally
with saline (1 ml/kg). The other four groups were given, respectively,
SA (40 mg/kg), Ala (20 mg/kg), GABA (20 mg/kg), or SA 
 
1
 
 Ala (40 
 
1
 
20 mg/kg). The amounts of chemicals injected were calculated from
published data for Ala and GABA (15) and from data on the com-
plete, stable inhibition of Ala-dehydrase activity with SA (16, 17). All
the injections were given during each alternating light and dark
phase, every 12 h. Half of the rats were killed after 1 d (two injec-
tions) and the others after 4 d (eight injections). Rats were killed by
decapitation in the middle of the dark period (19 h after light onset)
under a red light (0.4 
 
m
 
W/cm
 
2
 
 at the work surface) to avoid altering
melatonin secretion. The blood was collected, centrifuged, and frozen
at 
 
2
 
70
 
8
 
C for melatonin and TRP measurements. The pineal glands
were quickly removed and in each group two of them were frozen im-
mediately and stored at 
 
2
 
70
 
8
 
C for NAT and HIOMT activity assays.
The remaining pineals were kept in oxygenated Krebs-Ringer solu-
tion in an iced water bath until their transfer to the perifusion cham-
bers. The perifusion protocol has been described previously (18).
Briefly, the perifusion system consisted of a plastic column closed
with two pistons, a thermostatic bath which maintained the tempera-
ture at 37
 
6
 
0.5
 
8
 
C, and a peristaltic pump. Pineal glands (two per
chamber) were perifused for 3 h with Krebs-Ringer solution alone
(pH 7.4, bubbled continuously with 95% O
 
2
 
/5% CO
 
2
 
) for the control
group, and with Krebs-Ringer containing 1 mM Ala, 1 mM GABA,
or 0.8 mM SA, adjusted to pH 7.4 for the other groups. Effluent peri-
fusate fractions (10 min) were then collected into glass tubes over the
next 5 h and stored at 
 
2
 
20
 
8
 
C until assayed for melatonin. Lastly, the
adrenergic response of the pineal glands was evaluated by perifusing
them for 30 min (min 240–270) with 10
 
2
 
4
 
 M NE in Krebs-Ringer (19).
 
Pinealocyte cell culture.
 
Pineal cells were dispersed as previously
described (20). Pineal glands from 3-wk-old rats were rapidly minced
and rinsed in buffered saline: 0.1% BSA, 0.36 mM CaCl
 
2
 
, 25 mM
Hepes-NaOH, pH 7.3, 5 mM KCl, 137 mM NaCl, 0.7 mM Na
 
2
 
HPO
 
4
 
,
penicillin (100 U/ml), and streptomycin (100 
 
m
 
g/ml). Cells were dis-
persed by incubation with 6.4 U/ml trypsin and 8.1 U/ml DNase in sa-
line solution for 30 min at 37
 
8
 
C. They were suspended in DME me-
dium containing 10% FCS, 2 mM glutamine, 100 U/ml penicillin, and
100 
 
m
 
g/ml streptomycin. Aliquots (2–10
 
5
 
 cells in 0.5 ml) were placed
in sterile Eppendorf tubes. The culture was continued in an incubator
at 37
 
8
 
C under an atmosphere of 5% CO
 
2
 
 in air. All drugs (Ala, SA,
and GABA) were dissolved in H
 
2
 
O as 100 
 
3
 
 stock solutions. Experi-
ments were performed on cells cultured for 24 h. Each drug was
tested on cells cultured in medium alone and in medium containing
10
 
2
 
8
 
 M isoproterenol (the 
 
b
 
 adrenergic stimulator). The cultured cells
were pelleted (10,000 
 
g
 
 for 10 s) and resuspended in 0.5 ml fresh me-
dium. Drugs were added to final concentrations of 10
 
2
 
4
 
, 10
 
2
 
5
 
, or 10
 
2
 
6
 
 M
(5 
 
m
 
l aliquots) and incubation continued for 6 h. The cells were re-
moved by centrifugation (10,000 
 
g
 
 for 10 s), and the medium was col-
lected and frozen for melatonin assay.
 
Assays.
 
Plasma Ala was measured by a fluorometric optimized
Figure 1. Paradox of low circulating melatonin and high TRP in acute 
attacks of AIP. A specific 50% PBG deaminase deficiency character-
izes the AIP; it is shown as a horizontal arrow between Ala and 
uroporphyrinogen III (URO III). Bold arrows indicate increasing 
( ) or decreasing ( ) amounts of metabolites occurring in acute 
attacks of AIP. Depletion of the hepatic free heme pool leads to a 
lack of tryptophan pyrrolase activity and high circulating TRP levels. 
However, there were low diurnal and nocturnal plasma melatonin 
concentrations that could be linked to a GABA-like effect of Ala.
 106
 
Puy et al.
 
HPLC micromethod (21). Total plasma tryptophan was measured by
HPLC and fluorometric detection (22). Pineal NAT and HIOMT ac-
tivities were assayed according to Champney et al. (23). The intraas-
say coefficients of variation were 11% for NAT and 14% for HIOMT
(
 
n
 
 
 
5
 
 10), and the interassay coefficients of variation were 13% for
NAT and 16% (
 
n
 
 
 
5
 
 10) for HIOMT. The melatonin concentrations
in plasma and perifusate were measured directly by a modified RIA
method, using 
 
125
 
I-labeled melatonin (24, 25). The sensitivity of the
assay was 5–10 pg/ml, the only significant cross-reactant was 6-hydroxy-
melatonin (0.1%). The intraassay coefficient of variation was 8%
(
 
n
 
 
 
5
 
 10), and the interassay coefficient of variation was 11%
(
 
n
 
 
 
5
 
 10).
 
Statistics.
 
All results are expressed as means
 
6
 
standard error. The
effects of Ala, SA, and GABA on perifused pineals were measured as
the melatonin production in a chamber expressed as a percentage of
the mean concentration (“baseline level”) in the three fractions (210,
220, and 230 min) collected before addition of NE to the perifusion
system. Students’ unpaired 
 
t
 
 test was used to analyze the experimen-
tal data.
 
Results
 
The plasma Ala concentrations and weights of rats during the
3 wk of the chronobiological experimental protocols are
shown in Table I. The rats gained weight (
 
1
 
140%) during the
3 wk of synchronization and afterwards lost weight (
 
2
 
23%)
during the 4-d fast. Plasma Ala concentrations were increased
in the Ala, SA, and SA 
 
1
 
 Ala treated rats (
 
P
 
 
 
,
 
 0.001).
 
Effect of Ala, SA, and GABA on circulating TRP and
melatonin.
 
Total plasma tryptophan was markedly decreased
during activation of hepatic heme synthesis by Ala (
 
2
 
34%,
 
P
 
 
 
,
 
 0.01), and increased during the inhibition of heme synthe-
sis by SA (
 
1
 
24%, 
 
P
 
 
 
,
 
 0.05). Injections of GABA and SA 
 
1
 
Ala did not modify the total plasma TRP (Fig. 2). Plasma me-
latonin concentrations were unaffected by treating the rats
with Ala or SA for 1 d. However, 4-d-fasted rats had signifi-
cantly lower nocturnal plasma melatonin levels when given
Ala (
 
2
 
28%, 
 
P
 
 
 
,
 
 0.01), SA (
 
2
 
30%, 
 
P
 
 
 
,
 
 0.01), and GABA
(
 
2
 
39%, 
 
P
 
 
 
,
 
 0.01). Ala 
 
1
 
 SA treatment was even more effec-
tive (
 
2
 
51%, 
 
P
 
 
 
,
 
 0.005) (Fig. 3).
 
In vivo effects of Ala, SA, and GABA on pineal HIOMT
and NAT activities.
 
The nighttime activity of pineal HIOMT
was not altered by the drugs (Fig. 4 
 
A
 
). Nighttime pineal NAT
activity was significantly decreased by all four treatments: Ala
(
 
2
 
46%, 
 
P
 
,
 
 0.005), SA (
 
2
 
36%, 
 
P
 
 , 0.01), GABA (239%,
P , 0.01), and SA 1 Ala (249%, P , 0.005) (Fig. 4 B).
Effect of in vitro perifusion of Ala, SA, and GABA on pi-
neal HIOMT and NAT activities. The activity of pineal HIOMT
was not altered by 4 h of drug perifusion (Fig. 5 A). The pineal
NAT activity was significantly decreased after 4 h of perifusion
with Ala (230%, P , 0.01) or GABA (238%, P , 0.01) but
was unaffected by SA (Fig. 5 B).
Direct effects of Ala, SA, and GABA on melatonin produc-
tion in rat perifused pineal glands. The rates of melatonin re-
lease from perifused pineal glands were measured for the last
5 h of an 8-h perifusion. Melatonin release decreased during
the first 3 h of perifusion and reached fairly constant levels
during the following 5 h (18). The mean concentration of mela-
tonin between 200 and 230 min of perifusion was taken as the
Table I. Ala Concentrations and Weights of Rats during the Chronobiologic Experimental Protocol
Day 0 Day 21 Day 25
Weight Plasma Ala Weight Plasma Ala Weight Plasma Ala
grams mmol/liter grams mmol/liter grams mmol/liter
Control 11264 0.01060.01 25266 0.01360.01 198612 0.01860.01*
Ala 11563 0.01660.01 25768 0.0260.01 19969 1.2160.08*
SA 11166 0.01360.01 249610 0.01260.01 192612 1.4260.09*
SA 1 Ala 11063 0.01260.01 25065 0.0260.01 19068 2.4360.11*
GABA 10864 , 0.009 24766 0.01060.01 18667 0.0260.01
Day 0: Before synchronization; Day 21: Synchronized rats before fasting and drug injection; Day 25: After 4 d of fasting and drug injection. n 5 16 per
group. Rats were kept in a chronobiologic animal facility with a light intensity of 3.1–3.8 mW/cm2, compartments were equispaced, sound-proof, tem-
perature-controlled (2161.08C), and provided with filtered air. Ala (20 mg/kg), SA (40 mg/kg), and GABA (20 mg/kg) were injected intraperito-
neally. Controls were injected with saline. Results are mean6SEM. *Difference from pretreatment (P , 0.001).
Figure 2. Plasma tryptophan concentrations. Effects of the heme pre-
cursor Ala, the heme inhibitor SA, a combination of Ala 1 SA, and 
GABA on total plasma tryptophan in rats fasted and given drug in-
jections for 4 d (n 5 16 per group). Ala (20 mg/kg), SA (40 mg/kg), 
and GABA (20 mg/kg) were injected intraperitoneally. Controls 
were injected with saline. Injections were given every 12 h during 
each alternating light and dark phase. Vertical bars show SEM. Sig-
nificant difference from the saline controls: *P , 0.01; **P , 0.05.
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baseline (Fig. 6). The responses of perifused isolated pineal
glands to NE and drugs varied. SA did not significantly affect
the amount, range, or the duration of the melatonin released
by the pineal gland in response to NE (305618% for 180 min)
compared to controls (322622% for 160 min). But both Ala
and GABA canceled the NE stimulation, and, moreover, pi-
neal gland response to NE was shorter in time and lower in
amplitude: Ala, 18068% for 20 min; GABA, 160612% for 80
min; control, 322622% for 160 min.
Direct effects of Ala, SA, and GABA on melatonin produc-
tion by rat pineal cell cultures. The melatonin content of pineal
cell culture medium was unaffected by SA and significantly de-
creased by Ala and GABA compared to controls. Cells incu-
bated with 1028 M isoproterenol showed greater decreases in
melatonin content (Table II).
Discussion
A previous study on patients suffering from acute attacks of
AIP showed an increase in circulating TRP and a dramatic de-
crease in plasma melatonin, the pineal hormone synthesized
from TRP (8). The inhibition of melatonin production ob-
served in AIP could result either from a direct action of the
Figure 3. Nocturnal plasma melatonin concentrations. Effects of Ala, 
SA, Ala 1 SA, and GABA on nocturnal plasma melatonin concen-
trations in rats fasted for one (D1) and four (D4) days. Significant dif-
ference from the saline controls: *P , 0.01; **P , 0.005.
Figure 4. HIOMT and NAT activities after in vivo injection of Ala, 
SA, and GABA. (A) Effects of Ala, SA, Ala 1 SA, and GABA on 
the pineal HIOMT activity during the dark phase in rats fasted for 
4 d. Results were not significantly different from saline controls. (B) 
Effects of Ala, SA, Ala 1 SA, and GABA on the pineal NAT activity 
during the dark phase in rats fasted for 4 d. Significant difference 
from the saline controls: *P , 0.01; **P , 0.005.
Figure 5. HIOMT and NAT activities after in vitro perifusion of pi-
neal glands with Ala, SA, or GABA. (A) Effects of Ala, SA, and 
GABA perifused for 4 h on rat pineal HIOMT activity. Results were 
not significantly different from controls. (B) Effects of Ala, SA, and 
GABA perifused for 4 h on rat pineal NAT activity. Significant dif-
ference from controls: *P , 0.01.
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heme precursor Ala on pinealocytes, or it could result from a
lack of hemoproteins either via a reduced transmission of
light–dark signals from eyes to pineal receptors (hemoproteins
are photoreactive) or via defects in hemoproteins such as cyto-
chromes or NO synthase within the pineal gland. This rein-
forces a relationship between the clinical expression of this
dominant genetic defect and environmental factors (1, 8). This
study using a rat experimental model was designed to produce
a pattern of TRP and melatonin production similar to that in
AIP patients (8).
The decrease in total plasma TRP by Ala and its increase
by SA are in agreement with the findings of Badawy et al. on
the role of the hemoprotein TRP pyrrolase (5, 6). Giving rats
the heme precursor Ala resulted in saturation of their liver
TRP pyrrolase and activation of this enzyme; this enhanced
TRP catabolism, reducing its circulating availability for brain
uptake (7). As expected, the heme inhibitor, succinylacetone,
had the reverse effect on circulating TRP (4). However, TRP
production was not modified by the SA 1 Ala treatment, al-
though the combination of both drugs produced a higher Ala
Figure 6. Patterns of melatonin release from perifused pineal glands. Effects of 0.8 mM SA, 1 mM ALA, and GABA on melatonin release from 
perifused pineal glands before, during, and after stimulation with 1024 M NE. Each point is the mean6SE of data from three to six perifusion 
chambers (two pineal glands per chamber).
Table II. Melatonin Release from Pineal Cells in Culture
Controls Ala Ala Ala SA SA SA GABA GABA GABA
1024M 1025M 1026M 1024M 1025M 1026M 1024M 1025M 1026M
Baseline melatonin production
3.9360.25 2.3660.16* 2.3460.26* 3.1860.31 3.9560.31 3.8460.29 4.0160.19 2.1860.21* 2.3160.15* 2.9760.34‡
Melatonin production after adrenergic stimulation
65.3267.4 30.2563.15* 34.1265.21* 52.01611.63 60.92610.08 61.5668.5 59.3467.63 33.8463.84* 31.7862.32* 45.1268.41‡
Ala, SA, and GABA were added at decreasing doses (1024, 1025, and 1026M) before and after adrenergic stimulation with 1028M isoproterenol. Pi-
neal cells were incubated without glucose for 6 h, then cells were removed by centrifugation (10,000 g for 10 s), and melatonin was measured in the su-
pernatant. All results are mmol/liter6SE. *Difference from controls (P , 0.005); ‡difference from controls (P , 0.01).
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accumulation than a single treatment: it could be hypothesized
that exogenous Ala partially reversed SA inhibition on Ala de-
hydrase at a level that did not affect TRP production.
The low levels of melatonin found in vivo and in vitro were
not correlated with the circulating tryptophan level but were
clearly correlated with the high level of Ala. In vivo Ala and
SA caused large decreases in both melatonin production and
NAT activity. Ala was either exogenous (Ala treatment) or
endogenous (inhibition of liver Ala-dehydrase activity by SA).
Indeed, SA is the most potent inhibitor of Ala-dehydrase, the
second enzyme of the heme pathway, which catalyzes the con-
densation of two molecules of Ala to form the monopyrrole,
porphobilinogen (17).
The combination of both sources (Ala 1 SA) significantly
enhanced the decrease in plasma melatonin in response to the
higher concentration of circulating Ala. These data were con-
firmed by the internal checks on plasma Ala concentration,
which showed increases with Ala, SA, and SA 1 Ala. A clear
decrease in melatonin production in vitro was also induced by
Ala, whereas SA did not alter either the concentrations of the
hormone, the NAT activity, or the response to NE. Thus, the
effect of SA in vivo and the lack of a direct effect on isolated
pineal glands confirms that the action of SA is mediated by en-
dogenous hepatic overproduction of Ala. Moreover, the pine-
alocyte cell culture experiments showed that endogenous Ala
produced by the pineal itself after direct SA inhibition of heme
synthesis had no effect on melatonin production, whereas ex-
ogenous Ala and GABA strongly decreased the production of
melatonin.
For many years, there has been a suspicion that Ala is
toxic, especially for nerve tissues, but this still remains to be
demonstrated (26, 27). In vivo, Ala penetrates the blood-brain
barrier poorly (2), and previous studies showed that Ala acted
on isolated organs but not on whole animals (15, 28). This
study is the first, to our knowledge, to demonstrate an effect of
Ala in vivo and in vitro in rats. Pineal gland vascularization is
outside that of the central nervous system and outside the
blood-brain barrier. These results therefore support the hy-
pothesis that Ala may have a toxic effect on melatonin produc-
tion, and indicate that a lack of heme, hemoproteins, or por-
phyrins are not likely to be responsible for the decrease in
pineal melatonin production.
Daya et al. (29) examined the effects of Ala on forebrain
tryptophan and serotonin concentrations and on the pineal
melatonin content. While Ala caused decreases in forebrain
tryptophan and serotonin, it did not alter pineal melatonin lev-
els. However, Ala was injected for only 1 d and food was pro-
vided ad lib. Our results also show no significant difference af-
ter treatment for 1 d. In a preliminary study (data not shown)
Ala, SA, and GABA failed to exert measurable effects in fed
animals. We began to see an effect on day 2, and the combina-
tion of fasting and treatment for 4 d unmasked the effect of
Ala on the pineal gland.
The action of Ala is mainly due to its structural analogy
with GABA (30). Ala can activate the GABA receptors on
motor neurons and primary afferents (31). Studies on rabbit
brain and rat jejunum have shown identical effects of Ala and
GABA (15, 32).
While there has been little work on the relationship be-
tween Ala and melatonin synthesis and/or release, the effect of
GABA on the pineal gland has been documented (33). There
are great differences between birds and mammals (34). In
mammals, GABA has a global inhibitory effect on melatonin
synthesis and its release (35). The addition of GABA to the
medium inhibits melatonin release from rat pineal organotypic
cultures (36). GABA inhibits NE-induced activation of NAT
in ovine pineal glands (35). Thus, GABA behaves as a modu-
lating inhibitory signal in rat, bovine, and ovine pineal glands
and is released by exposure to the natural transmitter NE and
impairs NE postsynaptic effects (36). The inhibition of nor-
adrenergic activity by GABA has been shown to be post and
presynaptic in rat pineals (36). Our perifusion system was able
to preserve post and presynaptic domains since the nerve ter-
minals innervating the pineal gland are known to need .24 h
to degenerate (37).
Our results show similar nighttime decreases in melatonin
release in vivo in rats given GABA or Ala. This decrease is as-
sociated with a decrease in pineal NAT activity but not in
HIOMT activity. In vitro perifusion of pineal glands from
GABA- and Ala-treated rats and pineal cell cultures showed
impaired response of pineal melatonin production after NE
stimulation. The adrenergic innervation of the pineal gland
plays an important part in the circadian rhythm of melatonin
via NAT activity. Therefore, our results strongly suggest a mi-
metic decreasing effect of Ala and GABA on pineal NAT ac-
tivity mediated by impairment of the noradrenergic stimula-
tion. These data could explain the low nocturnal plasma
melatonin concentration in rats.
In conclusion, Ala, SA, and GABA cause decreased pro-
duction of pineal melatonin in intact rats. The patterns of TRP
and melatonin production are similar to those in AIP patients.
We suggest that a decrease in melatonin production is induced
by an increase in Ala concentration and not by a lack of hemo-
proteins. We therefore propose that the biochemical mecha-
nism could be a “GABA-like effect” of Ala that decreases
NAT activity and blocks the pineal response to b adrenergic
stimulation. We also argue for the role in rats of Ala combined
with fasting in metabolic disturbances not only in isolated or-
gans but also in the intact animal. These findings could help to
improve our knowledge of the clinical expression of acute in-
termittent porphyria in humans. Finally, the pathophysiologi-
cal significance of these findings requires further examination
to explore any relationship between this frequent autosomal
dominant genetic disease and the influence of environmental
disturbances on its clinical manifestations.
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